Knight Therapeutics, Inc. (GUD.TO)

8.19 +0.24 (+3.02%) CAD  |  TSX  |  May 29, 16:00
More

Knight Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for GUD.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
HLS Therapeutics, Inc. Upgrade
Bausch Health Cos., Inc. Upgrade
Cipher Pharmaceuticals, Inc. Upgrade
BioSyent, Inc. Upgrade
Revive Therapeutics Ltd. Upgrade